Development and application of methods for the analysis of microarray gene expression data by Dysvik, Bjarte
 
Development and application of methods for the analysis of 













Department of Informatics 





This thesis is based upon studies conducted during November 2002 to June 2006 at the 
Department of Informatics, University of Bergen, Norway.  
 
First of all I would like to express my sincere gratitude to my supervisor, professor Inge 
Jonassen. Without his advice, patience and knowledge, this thesis would never have 
become a reality. Further I would like to thank my immediate microarray group at the 
university for their many hours of fruitful discussions and positive attitude. Specifically I 
would like to thank Trond Hellem Bø, Kjell Petersen, Anne-Kristin Stavrum and Laila 
Stordrange who all deserve much credit for this work. 
 
I would also like to thank all of my collaborators from the many different projects in 
which I have participated. This includes Sala O. Ibrahim, Mai Lill Suhr and Endre N. 
Vasstrand from the Department of Biomedicine and Dental Faculty-Periodontology at the 
University of Bergen; Petter Frost, Christiane Moros and Frank Nilsen from the genomics 
group, Institute of Marine Research, Bergen, Norway and Frédéric Pendino from the 
Department of Molecular Biology, University of Bergen. 
 
I would like to thank the Research Council of Norway that has funded this work through 
the Salmon Genome Project and the functional genomics program FUGE and its 
technology platform for microarrays. 
 
Additionally, I would like to thank several people helping with J-Express and MolMine. 
These are Kristin Sandereid, Øivind Enger and Erlend Skagseth from Sarsia Innovation 
and Vidar M. Steen from the Centre for Medical Genetics and Molecular Medicine, 
Haukeland University Hospital. 
 
Finally, but not least, I wish to thank my family who have always supported me, my good 
friends in Stavanger and most of all Wenche for enjoying life together with me. 
 
 




TABLE OF CONTENTS 
 
1 INTRODUCTION................................................................................................................................4 
BIOLOGY AND BIOLOGICAL SYSTEMS..............................................................................................5 
1.1 THE CENTRAL DOGMA OF MOLECULAR BIOLOGY ..........................................................................5 
1.2 FUNCTIONAL GENOMICS AND SYSTEMS BIOLOGY..........................................................................6 
1.3 HIGH THROUGHPUT TECHNOLOGIES FOR MOLECULAR BIOLOGY ...................................................9 
2 MICROARRAYS...............................................................................................................................12 
2.1 PRACTICAL USE OF MICROARRAYS ..............................................................................................14 
2.2 DESIGNING MICROARRAY GENE EXPRESSION EXPERIMENTS........................................................15 
3 MICROARRAY DATA ANALYSIS................................................................................................21 
3.1 IMAGE ANALYSIS ........................................................................................................................21 
3.2 EXPRESSION QUANTIFICATION....................................................................................................22 
3.3 FILTERING ...................................................................................................................................24 
3.4 NORMALIZATION.........................................................................................................................24 
3.5 EXPRESSION DATA ANALYSIS.....................................................................................................28 
3.6 GENE EXPRESSION ANALYSIS .....................................................................................................29 
3.7 MICROARRAY RESULT VALIDATION ............................................................................................34 
4 MICROARRAY DATA ORGANIZATION AND STORAGE......................................................37 
4.1 MGED AND THE MICROARRAY GENE EXPRESSION (MAGE) STANDARD...................................37 
5 THE J-EXPRESS SOFTWARE .......................................................................................................40 
6 SUMMARY OF PAPERS .................................................................................................................45 
7 FURTHER WORK............................................................................................................................50 




The use of high-throughput technologies in molecular biology has opened the way to a 
post-genomic era. Scientists are no longer limited to study just a handful of genes or 
proteins at the time, but can now screen full genomes and study complete biological 
systems more efficiently than ever before. The introduction of microarrays has 
revolutionized the way gene expression studies are performed and is already leading to 
important medical discoveries. The technology is however still considered to be in its 
infancy, with many problems still to be solved.  
 
High throughput generally means a lot of data, which needs to be organized and analyzed 
in an effective manner. Most available technologies for generating large amounts of 
biological data such as microarrays, 2d-gels and mass spectrometry focus on quantity at 
the expense of accuracy. This, together with the fact that it is hard to effectively store and 
make sense of millions of measurements for a single experiment, makes the use of 
computers unavoidable. Bioinformatics is an emerging field where informatics and 
biology join forces by applying informatics expertise to biological problems.  
 
This thesis will focus on two topics. First the analysis of new proprietary data produced 
by collaborators, and second, the development of new methods for high throughput data 
analysis and preparation. The goal is to increase knowledge and understanding of 
microarray technology and use this knowledge to develop novel methods for improving 
the quality of microarray results. 
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Biology and biological systems 
This section is mainly based on two sources: [1, 2]. 
1.1 The central dogma of molecular biology 
The central dogma in molecular biology describes the process in which information 
stored in a DNA molecule is transcribed to form an mRNA molecule and further 
translated to a protein. A protein in its simplest form is a chain (sequence) of amino acids 
(some 20 different ones), each of which has very specific properties such as charge and 
size. Each amino acid corresponds to a triplet (three succeeding bases) in the DNA 
sequence. By composing the proteins of specific amino acid sequences, they get specific 
properties which determine the proteins’ function. Some proteins are used as structural 
components and building blocks, while others have more active roles such as enzymes 
and regulatory proteins (see Figure 1). For a cell to create a certain protein, the DNA 
sequence corresponding to the protein must be correct and both the transcription and 
translation machinery must be accurate. A single error in the transcribed sequence may 
result in total function loss for the new protein. 
 
 
Figure 1:  From genes to proteins: between coding exons are non-coding introns which 
are spliced out before translation. Such introns are found in most eukaryotes (cells with a 
nucleus).After translation, the chain of amino acids is folded to form a functioning 
protein (here represented by a cartoon model).  
 
Genetic mutations are changes in the DNA caused by events such as copying errors or 
radiation. These can be harmless if repaired by the cells genetic repair apparatus or if they 
occur in non-functional areas, but problematic and even fatal if occurring within the 
coding or regulatory area of a gene (for instance sickle cell anemia which is caused by a 
single mutation at codon 6 of the β-globin gene).  
 
For a cell to function properly, it needs to produce the correct proteins in the correct 
amount as the surroundings and internal environment changes. This process is called gene 
regulation and takes place at several different levels, including synthesis of RNA 
transcripts, posttranscriptional processing of mRNA, mRNA and protein degradation, 
translation, posttranslational protein modification and protein transport. Gene regulation 
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is influenced by various mechanisms, such as outside signals, stress response and the cell 
cycle. For instance, the expression of certain enzymes may increase or decrease as the 
organism’s food sources change or are depleted. 
 
Gene regulation defects can be fatal for a cell and is the cause of many diseases. Some 
proteins operate as protein complexes or in functional assembly lines where the product 
of one protein is the source of another (e.g metabolic pathways [3]) and therefore depend 
on joint regulation. Regulation failure in a single component may result in a completely 
useless protein complex or a metabolic pathway with a devastating bottleneck [4]. 
 
By using new technology, it is now possible to monitor the expression change for 
thousands of genes simultaneously, and thereby effectively spot regulation disorders. 
This technology will be thoroughly discussed in the coming chapters. 
 
1.2 Functional genomics and systems biology 
Functional genomics and systems biology  [5] (A portal for systems biology: 
http://www.systems-biology.org)  are some of the hot topics in molecular biology today. 
New technologies make it possible to look beyond the expression of single genes, and 
even single regulatory networks [6] and try to understand how the complete system of a 
cell behaves. This is accomplished by building models based on knowledge about single 
genes [7], gene interactions and regulatory processes. These models are constantly 
refined through scientific experiments to increase prediction rates. The ultimate goal is to 
be able to understand the entire biological system and use this to predict how an organism 
reacts to a certain stimuli without going to the laboratory at all, but simply input the 
stimuli as a parameter to a computer model. A predictive computer model is also a proof 
of a true understanding of the system. This is the field of systems biology; an 
interdisciplinary field studied by computational biologists, statisticians, mathematicians, 
engineers, physicists and computer scientists. One important factor in this field is the use 
of computers to analyze, organize, store and query large quantities of data generated by 
high throughput methods. In addition, computers are used to build models and simulate 
systems to verify or reject additional hypotheses. 
 
A biological system can be simulated with a mathematic model. To test the model, effects 
of perturbations such as gene knockouts can be predicted mathematically and compared 
to real life perturbations. When testing new hypotheses, a sufficiently accurate model can 
then be used as a filter for selecting the most promising experiments. 
 
Systems biology can be divided into four problem areas. These are: (1) understanding the 
structure of the systems, such as genes, signal transduction and metabolic pathways, (2) 
learning the dynamics of such systems, (3) developing methods to control the systems 
and (4) developing methods for designing and modifying new systems for desired 
properties.  
 
The system structures can for instance be regulatory relationships of genes, protein 
interactions or physical structures of cells. The system dynamics describes how a system 
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behaves over time and responds to external stimuli. Some refer to these two first areas as 
“parts lists” and “connections” and they are the constituent parts of the system. 
Controlling or building new systems is often the ultimate goal. For instance, when 
knowledge about the processes leading from a normal cell to a cancer cell is understood 
and an accurate model is established, the next step is to apply methods to reverse this 
process and have the cell return to the normal state or enter apoptosis (programmed cell 
death). 
 
The actual technologies needed for systems biology to be a realistic science will be 
discussed in the next chapter, but a key factor is comprehensiveness. For instance, the 
complete genome of baker’s yeast (Saccharomyces cerevisiae) was sequenced in 1996, 
and shortly after a microarray for analyzing mRNA expression for nearly all open reading 
frames (potential proteins) became available (Patrick O. Brown’s laboratory at Stanford 
University. http://cmgm.stanford.edu/pbrown). Using this microarray, scientists could 
now measure gene regulation, build and test models based on gene expression 
measurements for all potential genes 
Metabolic pathways 
Systems biology can for example be used to model metabolic pathways [8]. Figure 2 
shows how the KEGG database (http://www.genome.jp/kegg) represents the citrate cycle. 
This pathway shows how enzymes work in an assembly-line like fashion to extract 
energy by converting metabolites from high energy containing molecules to lower energy 
containing molecules. 
 
Modeling pathways like the citrate cycle can be done in a bottom-up approach where the 
individual components are identified and studied before the “global” structure of the 
system is formed and tested. When a new organism is studied, existing models can be 
applied in a top-down approach where individual components are identified by for 





Figure 2:  The citrate cycle (left) and the description of structural components and 
interactions (right). Charts generated by the KEGG database (Kyoto Encyclopedia of 




The MetaCyc [9] database is another database with systems biology information. It 
contains over 700 metabolic pathways curated from scientific experimental literature and 
combines biological knowledge like pathway information (including reactions and 
compounds) with genes and protein products. It is also possible to query the MetaCyc 
database using sequence information to look for known pathways and genes in new less 
studied organisms in a bottom-up like fashion.  
Gene nomenclature and Gene Ontology  
For a description of a biological system like the citrate cycle to be of any value to other 
scientists than its discoverers, it is important that the components making up the system 
are uniquely defined. Many efforts have been made towards creating one single 
standardized nomenclature for genes, but scientists are still using several of them 
simultaneously to be sure the genetic component is uniquely recognized. In its simplest 
form, a gene could be identified by its sequence. A single gene can however go trough 
post-translational modifications, and thus end up as different functional molecules, which 
makes gene identification a challenge. Polymorphisms, splice variants, mutations, 
functions and even orthologs in other sequenced organisms are valuable information that 
must be accessible, preferably in centralized databases. Some of the most accessed 
databases with such data publicly available are GenBank 
(http://www.ncbi.nlm.nih.gov/Genbank) and UniGene 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene). 
 
Gene Ontology [10-12] is a project that aims at defining an accurate, dynamic and 
controlled vocabulary which can be applied to gene and protein roles. It is dynamic in the 
sense that it is not limited to certain organisms. This is particularly important when 
transferring biological roles between organisms, such as searching for homologous genes 
and pathways in less studied species. The Gene Ontology is divided into three areas: 
biological process, molecular function and cellular component. Directed acyclic graphs 
for these three groups can be downloaded and mapped to many genomes. The graphs are 
organized in a form where nodes go from “more general” to “more specific”. For 
instance, Biological_process is a top node with a child called behavior which again has 
child nodes adult behavior, auditory behavior and behavioral fear response. 
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• all : all ( <367946 )  
o GO:0008150 : biological_process ( <128040 )  
 GO:0000004 : biological process unknown ( <33969 )  
 GO:0009987 : cellular process ( <78831 )  
 GO:0007155 : cell adhesion ( <1461 )  
 GO:0007154 : cell communication ( <12283 )  
 GO:0030154 : cell differentiation ( <3552 )  
 GO:0008037 : cell recognition ( <68 )  
 GO:0050875 : cellular physiological process ( <72062 )  
 GO:0050794 : regulation of cellular process ( <12772 )  
 GO:0007275 : development ( <13755 )  
 GO:0040007 : growth ( <3303 )  
 GO:0051704 : interaction between organisms ( <1443 )  
 GO:0007582 : physiological process ( <81248 )  
 GO:0043473 : pigmentation ( <98 )  
 GO:0050789 : regulation of biological process ( <15932 )  
 GO:0000003 : reproduction ( <4324 )  
 GO:0050896 : response to stimulus ( <15834 )  
 GO:0016032 : viral life cycle ( <306 )  
o GO:0005575 : cellular_component ( <117135 )  
o GO:0003674 : molecular_function ( <122771 )   
Figure 3:  Hierarchical representation of a small part of the GO structure (biological 
process and its child-node cellular process have been opened). The chart is generated by 
the AmiGO browser (http://www.godatabase.org/cgi-bin/amigo/go.cgi). A line in this 
structure contains the following parts: The first icon (plus or minus) shows if a node has 
child-nodes and if it is open (minus). The green I and pink P shows the type of relation to 
the parent node (is_a and part_of relations respectively). The next is the ID and name of 
the GO term. The number in parentheses on the end is the number of gene products 
associated with the GO term using a predefined database.  
 
1.3 High throughput technologies for molecular biology 
 
It has become fashionable to invent new terms to describe the global set of biological 
molecules or phenomena that is studies. Established terms include genome (the complete 
set of genes, or DNA of an organism), transcriptome (the complete set of transcripts), 
proteome (the complete set of proteins) and metabolome (complete set of 
metabolites). Studies and measurements of the various -omes are referred to as 
corresponding -omics (e.g. genomics, proteomics, transcriptomics, metabolomics) [13] 
and often involve use of high throughput technologies. 
 
The development of these technologies has happened in parallel with computers 
becoming increasingly powerful and affordable. The increased availability of computing 
power has been a prerequisite for the technology development and deployment. New 
algorithms, modeling techniques and specialized software including databases and data 
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processing functionality are constantly contributing to the growth of bioinformatics. In 
the following section we describe some of the high throughput technologies and their 
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Table 1:  Some of the most relevant high throughput technologies used in 
molecular biology and their low throughput counterparts 
 
Technologies based on molecule separation 
Gel electrophoresis is a method for separation of macromolecules, either nucleic acids or 
proteins on the basis of size, electric charge or other physical properties. 2D SDS- PAGE 
(2-Dimensional Sodium Dodecyl Sulfate – PolyAcrylamide Gel Electrophoresis) is 
probably the most widely used method for separating and identifying proteins and their 
abundance. The method separates proteins based on size in one direction and isoelectric 
point [2] in the other. After separation, proteins can be visualized by conventional 
staining techniques. For further identification of the separated molecules, the spots can be 
cut out of the gel and further processed by for instance mass spectrometry (ms) to identify 
the protein. Proteins can also be identified by mapping their location on the gel to a size-
isoelectric point library. 
 
Mass spectrometry is a method that can be used for separating molecules (e.g ionized 
proteins or peptides) based on their mass to charge ratios. Proteins in a sample are 
normally converted to peptides (short protein sequeces) using proteolytic enzymes. The 
peptides are then separated and subjected to mass spectrometry to identify and/or 
quantify them. It is also possible to apply the separation process first and then convert the 
separated proteins into peptides. The sequence of the peptides can be identified by 
mapping them to known mass/charge libraries or by using a method called tandem mass 
spectrometry (also referred to as ms-ms). Other ways of performing mass spectrometry 
include MALDI-TOF MS, LC-MS/MS and Ion trap-MS (the prefix is referring to 
different ways of generating charged peptides). 
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Technologies based on molecule attachment 
DNA Microarrays will be discussed thoroughly in the next chapters, but is briefly 
described here for comparison purposes. They consist of cDNA molecules (or 
oligonucleotides) with known sequences, referred to as probes, attached to a medium. 
These probes will attach to complementary labeled target sequences (mRNA or DNA) in 
the studied sample. When bound to a probe, a target molecule will emit a signal when the 
array is scanned. The strength of this signal will reflect the abundance of the bound type 
of molecule (e.g. abundance of a certain gene). 
 
Protein microarrays [16-18] are based on the same principles as DNA microarrays in that 
a “bait” molecule is printed on a solid medium and labeled target molecules are allowed 
to bind. Abundance is then confirmed and measured by label emittance. Baits are 
molecules that bind to specific proteins, for instance antibodies or parts of protein 
complexes. 
 
Many of the high throughput methods used in molecular biology have their strength in 
the number of measurements performed simultaneously, but often lack the accuracy 
associated with their low throughput conventional counterparts. For many experiments, 
the objective is to identify small sets of genes or proteins responsible for phenotypical 
differences. To increase confidence, interesting results from high throughput experiments 
should be verified by more accurate low throughput methods, for example quantitative 
real-time PCR [19] and Northern blot hybridization. 
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2 Microarrays 
Microarray technology is very diverse with many variants and applications [20, 21]. Two 
of the first microarrays are the first Genechip® from Affymetrix [22] (www.affymetrix 
.com; Figure 5 and 6) and the first Arabidopsis microarray [23] from Patrick O. Brown’s 
laboratory at Stanford University. These represent early versions of two different ways of 
producing a microarray (on-array synthesis using photolithography and printing of 
cDNAs/PCR products). 
 
Microarrays commonly contain a large number of elements of the same type in a 
relatively small area. Each element can be a probe for a particular molecule species, e.g. 
the probes can be complementary (in the Watson-Crick sense) to labeled poly-nucleotides 
(typically cRNA or cDNA) or antibodies for a particular protein species. Another type of 
microarray contains miniaturized 'laboratories' so that a large number of identical 
experiments can be performed in parallel within a small area (lab on a chip, see e.g. 
http://www.rsc.org/Publishing/Journals/lc) 
 
Microarrays are produced by printing or synthesizing the probe molecules in separated 
areas on a solid surface such as glass or nylon. Figure 4 shows how to use a two-channel 
printed cDNA microarray to find genes differentially expressed between a test sample 
and a reference sample. In literature, there have been some disagreements between the 
terms probes and targets. In this text we will follow the suggested definitions from “The 
Chipping Forecast” (a supplementary to Nature genetics, January 1999, Volume 21) 
where probes are the molecules immobilized on the microarray substrate and targets are 
the molecules whose abundance is measured. In addition, we refer to the printed probes 
as genes, while in practice the actual molecules measured can be other kinds of molecules 
such as DNA segments. Finally, we refer to areas on the microarray where a certain 
molecule is measured as a “spot”, while in general the area may not resemble spots at all 
(such as for Affymetrix arrays). 
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Figure 4:  Outline of a typical two-channel microarray study. The left side outlines the 
printing process, the middle represents labeling and hybridization and the right side 
represents scanning and image/data analysis. 
 
This thesis will focus on the analysis of data from mRNA-measuring microarrays, but 
many of the challenges and problem areas are common for most microarray technologies. 
Different types of mRNA arrays exist, but the major versions are those synthesized base 
by base directly on the array (in situ synthesized arrays such as the Genechip ® from 
Affymetrix, see Figure 5), those synthesized off-chip and printed in spots (pre-
synthesized oliogo arrays) and those created by printing spots of cDNA (cDNA-arrays). 
The differences in price and precision have long made Affymetrix arrays a preferred 
technology for the industry and cDNA arrays for academic institutions [24, 25], but new 
companies have started to deliver accurate arrays for academic labs (e.g Applied 
Biosystems and Agilent). cDNA arrays have to some extent been replaced by oligo arrays 
because of their seeming lack of precision, but are still frequently used, much because 






Figure 5:  The photolithography synthesis process for Affymetrix Genechips ® (Figure 
from Affymetrix web site).  
 
 
Figure 4 shows a typical two-channel microarray experiment outline. mRNA is extracted 
from a test sample, reverse transcribed and labeled with a dye. The same procedure with a 
different dye is performed for another sample (often a common reference for multiple 
array studies) and both samples are then exposed to a microarray where the labeled target 
molecules will hybridize to the printed probes. By scanning the array at different 
wavelengths (corresponding to the label emittance), a comparative signal for the 
abundance of certain transcripts can be found. 
 
 
                     
 
Figure 6:  Two common types of microarrays. A custom cDNA array printed on glass 
(left) and an Affymetrix Genechip ® (right). 
 
2.1 Practical use of microarrays 
In an early study by Alizadeh et. al. [26] microarrays were used to analyze the expression 
profiles of several thousand genes in large B-lymphoma, a malignant cancer in the 
lymphatic system. In this study, the authors discovered two different groups of patients 
based on the gene expression patterns. By looking at the mortality rates, it became clear 
that these groups had significantly different survival rates. The same study also revealed 
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gene groups with different expression patterns between the patient groups. The outcome 
of this study shows the potential of microarray technology in regards to diagnosis, 
prognosis as well as opportunities towards therapeutics and biomedical research [27]. 
Similar studies have revealed analogous results for other genetic related diseases, such 
human breast [28] and skin tumors [29], leukemia [30], colon cancer [31], prostate cancer 
[32], small round blue cell tumors (SRBCTs) [33] and brain tumors [34]. 
 
Besides cancer studies, microarrays has been used in a variety of problem areas within 
functional genomics. Derisi et. al [21] used a microarray to monitor expression change in 
yeast as it changed its metabolism from fermentation to respiration.  
 
Customized arrays have been used to discover genetic alterations such as sequence 
variation [35] and screening of genomic imbalances, e.g. genetic amplifications and 
deletions (Comparative Genomic Hybridization arrays, CGH) [36, 37]. Gene expression 
in relation to growth and development has been studied for organisms such as drosophila 
[38] and malaria [39] to find genes turned on and off in metamorphosis and other steps of 
the life cycle. Understanding the developmental regulation of these genes can lead to 
effective drug therapies by blocking regulation of important genes to prevent maturity 
and propagation of for instance malaria and malaria carrying mosquitoes. 
 
The examples mentioned here are only a few of a large and growing number of studies 
using microarray technology. A search in PubMed 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed) with the term ‘microarray’ 
returns 12932 hits at the time this was written (7 june 2006). Approximately 50% of these 
were added since 1.1.2005. In addition, the query ‘microarray and cancer’ return 4562 
hits underlining the importance of this technology in cancer research. 
 
2.2 Designing microarray gene expression experiments 
The first and probably most important step in setting up a microarray experiment is to 
select an experimental design [40-47] that will answer the correct questions at an 
affordable cost. Typical questions that can be answered with microarrays are: 
 
• What is the difference in gene expression between normal tissue and disease 
tissue? 
• What is the gene expression difference between disease tissues in different stages? 
• Which genes are changing in expression as an organism grows? 
• Which genes are changing in expression when a particular gene is knocked out? 
• Which genes are changing in expression as an organism changes form 
(metamorphosis)? 
• Which genes are changing in expression when a drug is injected, and how much 
do they change? 
• Which parts of the genome are transcribed? 
• Are there any genetic deletions or duplications in chromosomes from a tumor 
sample compared to healthy chromosomes? 
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The design of a simple microarray experiment can be divided into three different layers 
[47]. In the top layer, biological objects (such as mice, patients, cell lines etc.) are 
assigned to variant groups (treated, not treated, disease state etc). In the middle layer, 
mRNA is extracted from each of the biological objects and labeled. The labeled samples 
are then hybridized to their treatment counterparts in a way that maximizes information 
about the biological question at hand. The bottom layer involves array design and the 
physical layout of spots. The many sources of variation in a typical microarray 
experiment can be distributed among these three layers. Biological variation occurs in the 
top layer and is often the main focus of the experiment. By carefully choosing the 
samples to include in the experiment, it can be possible to correlate treatment directly to 
gene expression, and rule out gene expression caused by other genetic or environmental 
factors. Technical variation appears in the mid-layer and is introduced in every step from 
obtaining the samples to fixing the molecules to a microarray. This includes extraction, 
labeling and hybridization. Measurement error is introduced in the bottom layer and is 
associated with reading the signals emitted by the labeled molecules.  
 
One of the fundamental questions when defining a threshold of accuracy needed to obtain 
meaningful microarray results is when, where and how to use replicates. More replicates 
should normally lead to better results, but the cost of microarrays, chemicals and work-
hours requires scientist to balance cost, confidence and efficiency against the desire to 
explore more experimental conditions. The variance from the two higher layers is usually 
the target for most microarray experiments and replications should be incorporated in 
such a way that this variance can be addressed. In a publication in Nature [47], Gary A. 
Churchill claims that correlation between replicate spots on a single microarray will 
normally exceed 95%, that correlation between spots on two microarrays with the same 
hybridized material is likely to fall between 60 and 80% and that the correlation between 
spots on two microarray hybridized from individual inbred mice may be as low as 30%. 
Although this paper was published in 2002, and recent studies suggest that this number 
may be somewhat higher (and probably very dependent on the technology used), it 
demonstrates the problem with reproducing microarray studies. It also shows that it is 
possible to reduce variation in the experiment by limiting the samples to come from 
fewer biological replicates. The power of scientific hypotheses and conclusions made 
from such experiments will however be lower than those based on more biological 




Identical probes on same chip Measurement error 
Same labeled target hybridized on two or more arrays Technical variance. 
Hybridization and 
quantification effects 
Same sample re-labeled Technical variance. Labeling 
effects 
New extraction of targets from the same source sample Technical variance. Extraction 
effects 
Different source from the same treatment group (treated, 
non-treated, disease etc.) 
Biological individual variation
 
Table 2:  Examples of replicates and what they address. 
 
 
Hybridization design and chip design are two important parts of a microarray experiment. 
Hybridization design deals with questions such as which samples to hybridize, use of 
biological replicates and sample size. Chip design involves everything from chip material 
to the actual immobilization of probes to the chip surface and deals with important 
challenges such as probe layout, probe density and probe sequence. Probe replication is 
simply repeated spotting of the same probes in different locations on the array which 
increases precision of the measurements. Printing multiple spots of the same probe is 
often called within-array replication and is a relatively cheap form for replication as long 
as there is physical space on the array. To measure effects such as local background 
fluctuations in the foreground signal, these should be placed randomly across the array 
instead of side by side. If other sources of variation are present on the array (such as pin-
groups or sub-arrays), assignment to these should be randomized to prevent confounding 
effects. 
 
Microarray chip design involves: 
• Chip substrate selection  
• Probe attachment mechanisms 
• Selection of spot size, between spot distance and spot layout (e.g. quadratic or 
diamond layout)  
• Physical array size 
• Number, size and arrangement of sub-arrays 
• Type, arrangement and number of controls on the array 
 
Hybridization design involves: 
• Samples to hybridize 
• Hybridization schemes (pairwise hybridization, common reference hybridization 
etc. (see Figure 8)). 
• Use of replicate arrays 
• Use of dyes/emittance  
• Number of samples and hybridizations 
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• Order of hybridizations 
• Batches of hybridizations 
• Personnel (experimentalist, technicians etc.) 
 
 
Technical variance and measurement error can reduce or even completely obscure the 
biological variance. The sources of technical variation and measurement errors, often 
referred to as nuisance effects or nuisance factors, are many and not completely 
understood. Some are however identified (such as dye and array effects) and should be 
dealt with prior to downstream expression analysis. Other sources, such as lab habits are 
more difficult to control. Many factors are also influencing each other. The potential 
number of variation sources for as few as 4 factors could result in as many as 24=16 
possible experimental effects [46]. For an experiment with the factors Arrays A, Dyes D, 
Varieties V (factors of interest), and Genes G, there are four direct effects A, D, V and G, 
six two factor effects, AD, AV, AG, DV, DG and VG, four three factor effects, ADV, 
ADG, AVG and DVG, and one four factor effect ADVG. The experiment should be 
designed in such a way that none of the known nuisance effects are confounding with the 
experiment objectives. For instance, if the design is a paired design using a two-channel 
array with normal samples in one channel and disease samples in another, the dye effect 
confounds disease-state and it will be difficult or impossible to determine how much of 
the signal is caused by dye effect and how much is caused by biology. Instead, the 
samples should be balanced between the two dyes so that an equal number from each 
experimental state or treatment group is labeled with each dye. Dye-swap is a popular 
approach to reduce technical variance caused by dye effects in two-channel microarrays, 
and prevent this from confounding with the experimental objectives. Dye swaps can be 
applied to technical replicates so that each sample is hybridized two times, one with each 
dye. For direct hybridizations such as treatment vs. control, this means two arrays to 
compare two samples. 
Random sampling from experimental groups is important for the validity of the statistical 
test used in a microarray experiment [47].True random sampling is hard to achieve, but a 
good representative selection is often obtainable. Many confounding effects can be 
removed by randomization. When arrays from different batches are used, one could 
randomly choose an array from one of the batches for each sample to prevent batch to 
confound with the treatment group. Similarly, for each sample, a random dye assignment 





Figure 7:  Log-log plot of the two channels in one two-channel microarray. Non-linear 
effects make normalization between channels more than a matter of simple linear scaling. 
As intensity increases, the mean ratio between the two channels also changes (F532 and 
F635 are the wavelength of the two dyes used for this array). The red line is a trend line 
showing the mean signal across diagonal windows in the log-log plot.  
 
Popular hybridization designs for two-channel arrays are the reference sample design, the 
pooled reference sample design, the loop design and the pairwise design [47, 48] (see 
Figure 8). In the reference sample design, one of the samples is used as reference channel 
for all other samples (often a “normal” or “time 0” sample). Although very simple, there 
are some major concerns for this design. For instance, it is a problem if the reference 
lacks a good signal (good being well above background signal) for probes expressed in 
other samples, as low signals are more often influenced by noise. In addition, two-
channel arrays are often combined to a single ratio or log ratio. If the denominator of the 
ratio is low and significantly influenced by noise, the result is much less trustworthy than 
with a strong denominator. The pooled reference reduces this problem by pooling many 
samples to create a strong reference base signal for most probes. For both common 
reference designs, the transitive nature of the signal comparison between two samples 
implies more experimental noise than a direct comparison. In addition, using one or more 
of the samples to create a reference sample causes disadvantageous dependencies 
between signals in the two channels. For the pooled reference, the relative signal in all 
samples will depend on the abundance of signals in all the other samples which can cause 
problems for many common statistical assumptions. With the loop and pairwise designs it 
is possible to circumvent this problem by direct hybridization the samples one wish to 
compare. A common problem with these designs however, is that whenever one array is 
bad or damaged, other arrays in the model may also be affected. In addition, while 
reference design experiments can be quite easily analyzed in the form of an expression 
matrix, loop and pairwise designs often require quite advanced analysis methods such as 
ANOVA and Bayesian models. An exception is the direct pairwise design where each 
sample is hybridized to a matched counterpart, such as disease tissue against normal 
tissue from the same patient. A disadvantage with this design, is that it does not allow 







Figure 8:  2-channel experimental design examples. Boxes represent samples and arrows 
represent hybridizations. The tip of the arrays represents one dye (red) and the tail a 
different dye (green). Dye-swaps can be used to remove confounding dye effects as 
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3 Microarray data analysis 
A possible outline of a typical microarray experiment (with emphasis on data analysis) 
could be: 
 
1. Biological question 
2. Experimental design 
3. Microarray experiment 
a. RNA extraction 
b. RNA labeling 
c. Hybridization 
d. Scanning 
4. Image analysis 
a. Segmentation 
b. Spot mapping 
5. Expression quantification 
6. Filtering 
7. Normalization 
8. Expression data analysis 
9. Biological verification and interpretation 
 
Optimizing the design based on the experimental objectives was discussed above, and is 
dealt with in the two first steps in this outline. Both have implications on all other steps as 
we shall see below. 
 
3.1 Image Analysis 
A microarray result is in its most primitive form a collection of intensity values with a 
two dimensional structure. For each x,y coordinate in a scanned area, there is an intensity 
Ix,y , and for arrays with more than one channel Ic,x,y (for channel c). This can be 
structured and viewed just like an ordinary computer image. We refer to each reported 
signal (Ic,x,y) as a pixel. Image analysis methods are used to locate the structures in the 
scanned array using I as input and producing as output a specification of the identified 
features. The features should correspond to the probes printed on the array and their 
geometry (morphology) should be accurately extracted. Reporter areas (where probes are 
printed) on the array must be found, bounded and accurately mapped to a reporter list. 
The reason for the need of accuracy in this step is that the reporter signal must be 
separated from a potentially disturbing background signal and, even more important, it is 
crucial to know what probe is actually printed there. In literature these steps are known as 
segmentation [49] (or spot finding) and spot mapping. Many methods have been 
proposed and implemented to efficiently read microarray images with hundreds of 
megabytes of information. Examples of segmentation methods for spotted microarrays 
are fixed circle, adaptive circle, adaptive shape and histogram based segmentation. Fixed 
circle is a very simple method for printed DNA arrays where a circle with the same 
diameter as a spot is placed in such a way that the pixels inside the circle are as different 
as possible from the pixels outside the circle. As spots rarely are perfectly circular, 
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background pixels are often treated as foreground pixels with this method. The adaptive 
circle technique reduces this problem by adjusting the circle diameter to exclude as much 
background as possible, but it is still inferior to the adaptive shape and histogram 
methods that use morphology and intensity distribution to separate foreground from 
background. 
 
3.2 Expression Quantification 
When the spots are found and separated from the background, the next step is to calculate 
an intensity signal for the spot. The foreground signal is normally a statistic (such as 
mean or median) based on the intensity values of all pixels determined to be inside the 
spot boundary (from the segmentation step). The correct method for calculating a “true” 
intensity is quite controversial, and most image analysis systems will report many 
different statistical measures and let the user choose the most appropriate. Some effects 
such as spot morphology and background intensity distribution could be used to 
determine the best way of segmentation and signal calculation. For instance, if most spots 
do not resemble circles, the fixed circle segmentation methods should be avoided.  
 
Another challenge is how to handle background influence to the foreground signal. If the 
foreground distribution is mixed with the background distribution and the background is 
uneven across the slide, a background correction method should be used. Background 
influence may change across print locations (typically between blocks) or arrays (see 
Figure 9A). Some image analysis systems give advanced background measurements 
where local and global background is taken into account so that this can be corrected by 











Figure 9:  Two images generated by the quality control feature in J-Express Pro. Figures 
are generated from two-channel cDNA image quantitation data from the GenePix 1.4 
software. A: Spatial distribution of background (log(median background(Channel1))). B: 
Spot location and pin-group (spots printed by the same pin, resulting in 4x4 squares in the 
Figure) together with spot size information. The intensity of each pixel corresponds to the 
size of a certain spot. Spots in pin-group 2 are for instance generally bigger than spots in 
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the filtering section below)
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3.3 Filtering 
In the image analysis step, some spots may be labeled as unreliable or unidentified by the 
software or by a user inspecting the data. The data from these spots should not be used in 
downstream analysis. Furthermore, it is customary to remove spots for which one 
suspects that the derived measures of (relative) hybridization will be unreliable. For 
example, if the intensity in the spot is not significantly stronger than the background 
signal, or if the variance of intensity in the spot area is too high, we may want to discard 
the spot in further analysis. Saturated spots are spots exceeding the range of values 
available to the scanning procedure. These can be corrected for by methods combining 
scans with different sensitivity (e.g. scans at different PMT voltages), but should be 
removed or tagged if uncorrected. 
 
3.4 Normalization 
As noted above, one of the objectives in the experimental design was to minimize the 
effects of unwanted biases. Still, some non-biological variation often ends up in the 
expression quantification data, and this should be corrected for whenever possible [50]. 
Normalization is the process where systematic bias from technical artifacts is reduced by 
making certain assumptions about the data. The aim is to adjust the data so that the 
resulting expression measurements are comparable in a probabilistic or statistical sense 
[27]. One assumption often made is that the total amount of transcription or the 
median/mean transcription in two or more measured conditions/samples is the same. 
Under this assumption, samples or channels can be scaled to an equal reference point (e.g 
mean, median or percentile) [51]. Such assumption must be valid in regards to an 
analogous biological assumption. For instance, if an assumption is made that the majority 
of genes do not change in expression between samples or that the distribution of gene 
expression values is the same, but the overall mean of the expression does change, such 
normalization can be fatal and will remove or reduce valuable biological information. 
 
The normalization procedure should be tailored to the technology used. It should also 
reduce effects from all known sources of obscuring variation [52]. Some microarrays 
contain blocks with spots printed by the same print pin. The print pins may have 
physically different tips which may print morphologically different spots (see Figure 9B). 
The print tip variance can be removed by including this information in the normalization 
assumption (e.g. the mean log ratio signal within a block should be 0). Similarly, spatial 
normalization can use probe location to remove a spatial bias. However, by dividing the 
data to be normalized into groups based on location or print tip, the statistical quantity of 
observations decrease and the method often becomes vulnerable to overfitting. 
 
If the experiment involves comparison of conditions/samples where one has reason to 
suspect that there are major changes in total transcriptional activity, other normalization 
methods such as those based on spiked in controls or constantly expressed genes (house 
keeping genes) can be used instead. Van de Peppel et al [53] have demonstrated how 
external controls and cell counting can be used in such experiments and how dramatically 
different the results are as compared to those obtained using the assumption about 
unchanged transcription level. 
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It is useful to visualize the relationship between pairs of intensity measurements (each 
from one array, or from one channel in a two-channel system) and log-ratios for a set of 
genes (probes). This is commonly done using MA plots (see Figure 11). It is not 
uncommon to observe an intensity dependent dye (channel) specific effect that shows up 
as a "banana shape" in these plots. There are normalization methods that correct for such 
effects, including spline [54] and local regression methods. The methods are based on the 
assumption that the total (or mean/median) expression level of most genes is unchanged 
also when one considers only genes falling within a local window along the intensity axis 
in an MA plot. The MA plot uses M as the y-axis and A as the x-axis where 
 




( )GRA ×= 2log  or ( )GRA ×= 10log  or 
( )
2
log 2 GRA ×=   
 
The MA plot is sometimes referred to as an IR plot (I = intensity and R = ratio). 
 
LOWESS [51, 55] (LOcally WEighted Scatter plot Smoothing) normalization is one of 
the most applied methods for normalizing two-channel arrays in the literature today (see 
Figure 11). Lowess removes intensity-dependent dye-specific effects from the features 












Print-tip lowess regression curves 
Figure 11:  Some normalization methods visualized by MA plots (generated with J-
Express). The median normalization shows the problem with linear normalization methods 
and although the median overall genes are unchanged, there is clearly some intensity 
dependent variation left. This variation is removed in the lowess normalization. In the 
print-tip lowess chart, the normalized data is not shown, only the source data with lowess 
normalization curves for each print tip. In the normalization result each of these curves 
will be straight, like in the upper right plot.   
 
One-channel arrays are usually normalized in a slightly different way than two-channel 
arrays because there are no dye-specific effects such as dye/intensity as there are for two-
channel arrays. Normalization in these arrays is often performed in regards to a single 
common reference (using methods similar to two-channel methods like lowess) or by 
making sure the distribution of intensities across all slides in the experiment is the same 
(e.g. quantile normalization [50], see Figure 12). The assumption made by the quantile 
normalization method is simply that the distribution of gene abundances is nearly the 
same in all samples. 
 
When comparing signals from different dyes in a two-channel experiment or from the 
same dye from multiple arrays, the goal is usually to see if the signals are significantly 
different. We can refer to such analysis as looking for genes with a certain fold-change. 
Due to many of the unwanted biases described above (dye effects etc.) the intensity 
signals can generally not be directly compared, but must first be calibrated in some way 
like normalization. A simple fold change analysis can be to calculate a ratio or a log ratio 
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between the two channels in a two-channel microarray. This is however a very simple 
analysis and it has been shown that the variance in many microarray studies is very 
intensity dependent [56], leading to an intensity-fold change dependency. If the variance 
is not normalized in a way that ensures the same variance across the whole intensity 
range, a fold change at intensity (R1,G1) will not be the same as a fold change at intensity 
(R2,G2). The process of normalizing the variance to create a more correct transformation 
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QNorm C vs B 
Figure 12:  Quantile Normalization of 3 Affymetrix Genechip ® arrays visualized in J-
Express. Top charts are MA plots with trend lines. Bottom charts are the corresponding 
histograms showing the intensity distribution. 
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3.5 Expression Data Analysis 
 
After filtering and normalization, the microarray experiment can be organized into a gene 
expression matrix where each gene is represented by a row and each sample by a column. 
For each gene i there will be a certain number of samples j and the expression of a gene 
in a sample can be indexed as exp(i,j). For simplicity, both within-array replicates and 
technical (array) replicates are, when present, often merged into a more robust composite 
signal. Alternatively, the individual measurements can all be retained and consistency 
among replicates can be used to assess reliability in downstream expression analysis. 
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Figure 13:  3 different ways of visualizing the same gene expression profile. 
 
After normalization there are often still unreliable values (usually those where the 
foreground signal is close to background) that should either be tagged with a quality 
measure or removed before expression analysis begins. Removing values (see filtering in 
section 3.3) will leave “holes” of missing values in the gene expression matrix if un-
filtered replicates do not exist. If individual genes or arrays with a very high proportion of 
missing values exist, these are often removed entirely from downstream analysis. 
However, if only genes and arrays with no missing values are kept, much valuable data 
will be removed. 
 
Some data analysis methods can handle missing values simply by not including them in 
calculations. However, many methods, such as those based on similarity measures, 
requires a complete expression vector (a valid exp(i,j) for any gene i and sample j). 
Similarity measures are used in many popular methods such as clustering and projection 
(e.g. multidimensional scaling). One of the most frequently used similarity measure is the 
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Euclidean distance metric where the distance from gene i to gene k given expression 
matrix x is given by the equation:  
 
( ) ( ) ( )2222211 ... kninkikiik xxxxxxd −++−+−=  
  
If for instance, gene i is missing a value in sample 2 (xi2) the calculation will fail or the 
distance will not be comparable to other distances in the data.  
 
Missing values can be estimated with a data imputation method [60]. Imputation is a 
process where patterns in the expression matrix are utilized to predict missing elements. 
The assumption underlying imputation methods is that the missing value would (if 
present) follow patterns present in the data. For instance, if two genes are correlated and 
one of them has one expression value missing, the value would be such that the 
correlation is preserved also in this point. Different imputation methods are able to 
capture and utilize different types of patterns in the expression data. The simplest 
imputation methods are those replacing missing values with an average of non-missing 
values in the same row or column. This was often performed in early studies, but has 
been replaced by much more sophisticated methods such as the KNN method [61] and 
LSimpute [62]. 
 
The KNN imputation method is one of the most popular imputation methods in literature 
and estimates missing values by locating the k gene expression profiles that most 
resembles the one missing a value. A weighted average is then calculated from the k 
similar profiles and put into the expression matrix. 
 
3.6 Gene Expression Analysis 
 
The analysis of a gene expression matrix can be performed on data from the expression 
matrix alone, or by including prior knowledge such as gene function or sample disease 
state to discover patterns and relations in the data. These two fundamental types of 
analysis are referred to as unsupervised and supervised data analysis respectively [63]. 
 
Unsupervised analysis methods include self-organizing maps, hierarchical clustering, k-
means clustering and principal component analysis (see Figure 14). Clustering methods 
[64] have been extensively used to analyze microarray analysis because of the way they 
reduce the data complexity by grouping together similarly expressed genes or samples. 
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Figure 14:  An unsupervised analysis example. Top left: Original time series data with 
one line per gene measured in 11 time points (log 2 sample vs. time 0 ratios). Top right: 
The same dataset clustered with a k-means clustering (k = 25). Bottom left: A 
hierarchical clustering sub-tree of the top left data. Bottom right: A principal component 
analysis (PCA) plot of the top left data with two areas shown in line charts. All charts are 
produced with the J-Express software. 
 
Supervised analysis is the other main group of analysis methods. With these methods, 
external information is utilized in search for coherence between patterns in the data and 
previously known properties such as sample class labels (diseased vs. normal) or gene 
groups (defined by for instance gene ontology terms or metabolic pathways). Examples 
of supervised analysis problem areas are classification [30] and methods for identification 











Figure 15:  Supervised analysis example. Significance Analysis of Microarrays (SAM) 
[65]. Top: Original dataset with two different sample class labels (green and brown). 
Center: The SAM interface in J-Express. The four top genes are selected and shown in 
black (bottom). These genes are clearly expressed at different levels in the two groups 
(high in most green samples and low in most brown samples).  
 
Identification of differentially expressed genes 
From a gene expression matrix and sample class labels, a frequent goal for microarray 
analysis is to find genes differently expressed between the classes. For two-class studies, 
this can be done simply by comparing the mean expression in the two classes (see Figure 
16). A more robust method is a t-test where the class variance is included in the equation 
and an even more robust method is SAM (Significance Analysis of Microarrays) where 
the variance parameter is controlled by ad-hoc statistics. Reducing the influence of 
variation in the statistics often give better results when handling microarray data. This is 
mostly because of the still rather inaccurate nature of microarray technology and the 
normally small number of samples in each group. 
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Feature selection and classification 
Samples studied with microarrays can often be grouped into classes with certain common 
properties such as tissue location or cancer progression. When such properties exist, a 
common objective is to find genes differing in expression between the classes. The 
expression of these genes can then be compared to the expression of the same genes in 
new unstudied samples to determine class membership. Additionally, it can be interesting 
to see whether there are patterns in the expression data that are shared between some 
samples but not others. Such patterns may for instance suggest that a certain type of 
cancer has two different expression patterns which respond differently to treatment [26]. 
Many methods for finding sample groups based on expression patterns exist, and are 
referred to as methods for class discovery. Finding genes with classification properties is 
normally referred to as feature selection [66, 67] and using patterns from these genes to 
classify new samples are referred to as class prediction or classification. 
 
Classification is normally performed in two steps: 1. Selecting features and 2. training a 
classifier rule [68]. For instance, a simple classification algorithm can “learn” that for two 
particular genes in a learning dataset with 20 normal samples and 20 disease samples, 
expression values are always high in normal samples and low in disease samples. For 
new samples, the algorithm (with the classifier rule) compares the expression values of 
these two genes to what it has learned and returns a prediction. The strength of the 
prediction in this example can be evaluated by studying the expression and variation of 
the learning set like a regular t-test (see Figure 16). Low within-class variations and high 
between group variations will most likely result in classifications with higher confidence. 
 
The classification method is often specialized to handle features with certain properties. 
This means that not all feature selection methods are directly compatible with any 
classification method. Bø et. al [32] for instance, showed that feature sets selected based 
on pairs of features (genes) outperformed those based on individual genes for some 
datasets (see Figure 16). The discriminate power of these pairs does however not apply 
when the features are regarded separately, which is the case for many known classifier 
rules. 
 
Feature selection does not necessarily mean extracting subsets of features. Many methods 
use weighting to include all features but differentiate their importance in regards to the 
classifier rule. For instance, an insignificant feature can be assigned a weight of 0.0, 
which generally corresponds to removing it from the list. 
 
Two ways of selecting features for classification exists: 1. using the classification method 
in the feature selection procedure, and 2. separating the classification method and the 
feature selection method. The first is also known as the wrapping approach while the 
latter is known as the filter approach. A good thing about the wrapping approach is that 
features are optimized for the classification function which ensures optimal classification 
success with the used feature set. A filter approach on the other hand can use previously 
implemented methods for feature selection to create feature subsets for new classification 
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methods. Compatibility between the feature set and the classification method is up to the 
user to verify. 
 
The methods mentioned above for finding features differentially expressed between 
groups can also be used in a filter approach to select features with good discriminate 
power. Both t-test and SAM would create feature lists well suited for a LDA [69] based 
classification method (see below). 
 
Feature subset selection is often referred to as being either “forward selection” or 
“backward elimination” when choosing the optimal number of features to use. Forward 
selection is a selection method where more and more features are added until a prediction 
rate stops increasing. Backward elimination is a similar method where the starting feature 
set is reduced until the prediction rate no longer increases. 
 
One of the simplest classification methods is the K-Nearest Neighbor (KNN) method that 
simply counts occurrences of class labels for the K most similar samples and returns the 
most frequent. Support Vector Machines [20, 70, 71] (see Figure 16) is another 
supervised method that finds an optimal separating hyperplane between members of 
different classes in an abstract space, such as the multidimensional space of a microarray 
gene expression matrix. Other classification methods frequently used for microarray data 
analysis are decision trees [72] and Linear Discriminant Analysis (LDA) [69]. 
 
 
Figure 16:  Feature selection and feature scoring. Left: Difference in expression mean 
between two classes. Middle: How pairs of genes can lead to better predictive power than 
each of them individually. Projecting the gene expression values (dots) on the blue line 
separates all samples perfectly. Right: SVM with a non-linear decision boundary. 
 
Cross validation can be used to test the power of a classification method. Given a dataset 
containing pre-classified samples, the basic idea is to leave out a portion of the data 
(prediction set) and “train” a classification function from the rest (training set). The 
classification function is then used to predict the left out samples which are compared to 
the “correct” labels. For establishing a stable and reproducible success rate, the training 
set and prediction set should be non-overlapping and multiple tests should be balanced so 
that all samples are cross validated approximately the same number of times.  
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Cross validation is often referred to as leave-k-out cross validation where k corresponds 
to the portion or number of samples extracted as prediction set. For instance, a leave-one-
out cross validation (or LOOCV) classifies each sample once using a classifier trained 
from all other samples. The good thing about leaving only one sample out is that the 
success rate can easily be compared to that of other classification methods. Comparison 
between methods where more than one sample is predicted either requires the list of left-
out samples or a mean of multiple cross validations (preferably with some variation 
measurements). Leaving only one sample out in the cross validation does however often 
lead to overfitting of the prediction model. More robust cross validation methods leave 
out a greater portion of the data, such as a third of the samples. 
 
Many methods used in supervised analysis of microarray data, like methods for creating 
feature lists and finding genes differentially expressed between classes, involves the 
testing of thousands of hypotheses. Controlling the increased number of type I errors 
(false positives) when testing microarray hypotheses (such as that a gene is differentially 
expressed between classes) is important because of the normally large number of genes 
that are measured simultaneously. The reason is that we are rarely interested in the 
intersection null hypothesis which is that all hypotheses are true or not, but instead the 
individual outcome of each single measurement. A very restrictive method for multiple 
testing correction is the Bonferroni procedure where the resulting p value is multiplied by 
the number of tests performed. In practice, a p-value cutoff at 0.05 in an experiment with 
1000 genes is changed to 0.00005 with Bonferroni correction. A more popular, and less 
restrictive procedure is to include a False Discovery Rate (FDR) [73, 74] with the gene 
set and p-values reported. This value gives an average fraction of false discoveries when 
a decision rule is applied repeatedly to a set of hypotheses, but does not reduce p-values 
or the number of features reported as significant. 
 
Permutation tests [30, 65] are often used to obtain a prediction score associated with 
feature selection methods and methods for finding genes differentially expressed between 
classes. This is done by repeatedly shuffling class labels and calculating new feature 
scores. The mean shuffled feature score is then compared to the unshuffled feature score. 
Permutation tests are especially efficient when the number of samples is sufficient to give 
a desired degree of confidence. Permutation methods also give more reliable correction 
for multiple testing. 
 
3.7 Microarray result validation 
A successful microarray experiment gives an answer to the biological question that was 
the starting point for the study. This may be a list of genes differentially expressed 
between two disease states, identification of new subtypes of a disease, or hypotheses 
about regulatory relationships. In most cases, results obtained using microarrays are 
validated using more accurate low-throughput methods such as quantitative real-time 
PCR, immunohistochemistry or northern blot hybridization.  
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Quantitative real-time PCR (polymerase chain reaction) is a method for logarithmic 
amplification of selected transcripts which are compared to standard controls. An 
approximate absolute copy number can then be established and compared to the result 
returned by the microarray experiment. The PCR procedure generally produces large 
amounts of gene copies by repeating a cycle of 3 steps: Denaturation (separating the two 
strands), annealing in the presence of primers (so that primers are attached to the single 
strands) and extention (rebuilding of new double strands). Because both strands are 
copied in each cycle, the increase of copies is exponential. 
 
Immunohistochemistry is a method for identifying the presence of cellular or tissue 
constituents (antigens) by antigen-antibody interactions. The antibody binding is then 
identified either by direct labeling of the antibody, or by use of a secondary labeling 
method.  
 
Northern blotting [14] involves the electrophoresis of the total mRNA for separation and 
blotting onto a membrane where a labeled probe is used for staining. It is a simple, 
frequently used method in molecular biology but has its weakness in that it requires 
relatively much mRNA. 
 
Using external information in gene expression studies 
As more and more analyses of molecular processes and regulatory systems are being 
completed, new methods including this knowledge in the data analysis are also emerging. 
For instance, patterns from unsupervised cluster analysis can be compared to metabolic 
and regulatory pathways or gene ontology groups to see if similar expression patterns 
may be caused by underlying biological gene regulation.  
 
Semi-supervised clustering [75] is a relatively new approach to microarray analysis. In 
this type of analysis, the data is partitioned into classes based on supplied annotation and 
analyzed to find partitions with predominant patterns (or vice versa). The term semi-
supervised comes from the combination of both un-supervised and supervised elements. 
A very simple form for semi-supervised analysis is simply to divide the data into groups 
corresponding to metabolic pathways or gene ontology groups and calculate a within-
group gene expression correlation. By calculating an average background correlation 
from permutation tests (as described in the feature selection and classification section), 






Figure 17:  Pathway analysis in the J-Express software. The table shows metabolic 
pathways in the malaria parasite (P. falciparum) having a gene expression standard 
deviation (across 7 time samples) below 0.5. The table shows pathway name, number of 
elements found both in the dataset and pathway, number of elements in the pathways, 
gene expression chart and a button for viewing pathway details. Note that many-to-many 
relations exist and this is the reason why 18 elements (genes) in the dataset match one or 
more of the 14 elements (genes) in the Citrate Cycle. 
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4 Microarray data organization and storage 
4.1 MGED and the Microarray Gene Expression (MAGE) 
standard 
The Microarray Gene Expression Database Group (MGED http://www.mged.org) was 
initiated at Cambridge, UK in 1999 with the purpose of establishing recommendations for 
microarray data annotation. The group released MIAME 1.1 (Minimum Information 
About a Microarray Experiment [76]) in April 2002, which is a document describing a 
minimum of information that should follow a microarray dataset for the experiment to be 
reproducible. Besides the MIAME working group, several other groups exist within the 
MGED society. The MAGE [77] group is responsible for the MAGE (MicroArray Gene 
Expression) object model (MAGE-OM, see Figure 18) which is the conceptual model for 
implementations such as the array express database and the MAGE software toolkit 
(MAGEstk). 
 
The reason for the MGED initiative was a great variety of new contributors to the 
microarray field, but no common language to describe the same “parts”. MGED was 
established in collaboration with many of the main industrial microarray suppliers such as 
Agilent, Axon and Affymetrix and have several main objectives: 
 
• Promote adoption of standards (MIAME and MAGE) for DNA-array experiment 
annotation and data representation 
• Assist development of academic and commercial MIAME and MAGE compatible 
software 
• Develop microarray data quality standards 
• Facilitate development and adoption of standards for describing high-throughput 
life science experiments (particularly microarray experiments) 







Figure 18:  Example of a class diagram from MAGE. The ArrayDesign overview. 
 
The MAGE object model also exists as an XML implementation called MAGE-ML 
(MAGE Markup Language). This makes it possible to encode any instance of the object 
model (containing actual data) as a sequential document to be sent over networks or 
exported to files.  
 
Many popular journals now demand microarray experimental data to be available in 
curated databases such as the ArrayExpress database. One of the simplest ways for 
scientists to transport the data from their local systems to a MAGE compatible database is 
to locally export it to MAGE-ML format using the MAGEstk toolkit (or a MAGEstk 
based software tool). The MAGE-ML package can then be sent to curators who will 
make sure it contains the information necessary and submit it to the database, where it 
can be made publicly available trough internet servers. 
 
Although the introduction of MAGE has made storage and retrieval of microarray data 
and experiment information easier, it still has some limitations. The MAGE object model 
is implemented in a way that maximizes compatibility with new structures and thereby 
increases the complexity. MAGE-ML output files are very complex and almost 
impossible to understand without a MAGE-ML reader that can rebuild the object 
structure. In addition, the toolkits for creating MAGE models lacked a structure for 
representing expression analysis in an effective manner. Our group has however added 
this feature to the MAGE software toolkit and implemented support for storing 
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downstream data analysis [78] (see Figure 19). This addition has been made available in 




Figure 19:  Two ways of storing microarray expression data analysis results using the 
MAGE software toolkits. Top: Original scheme for analysis organization with each 
analysis block containing input and output data. Bottom: Our contribution to the toolkits 
exemplified by a simple example. Instead of storing all in-between data, only the source 
and final data is stored together with all information needed to recreate the full analysis. 
 
The framework for pre-processing of data from image-analysis systems is flexible and 
allows for scripting and plugin of new novel methods. Import filters for most file formats 
are included in the software and for new unknown formats new parsers can be built 






























Example of the original 
MAGE-software toolkit data 
analysis result scheme 
Alternative (implemented) data 
analysis result scheme example 
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Low-level analysis and data preparation often ends with the compilation of a gene 
expression matrix. This is handled effectively by the J-Express software in a 
comprehensible manner. The expression matrix can be put through a replicate 
combination tool, a missing value imputation tool and a data transformation tool 
(intensity values to ratios, log ratios etc.) and finally end up in a project tree. This is the 
beginning of the next analysis phase: downstream analysis. Data analysis methods come 
in two versions in J-Express. One collection of tools is the unsupervised methods such as 
clustering and projections. Both genes and samples may be tagged with group 
information such as functional gene group, metabolic pathway, sample disease state or 
sample location. This information can then be used directly in the unsupervised analysis 
to evaluate results in a semi-supervised fashion. Group information can also be used 
directly in the supervised methods such as t-tests and SAM. Pathway and Gene Ontology 
analysis tools can be used to discover over-representation of genes with special 
expression patterns in functional groups or metabolic patterns.  
 
The hierarchical structure of the data analysis lets the user start with a complete gene 
expression matrix and extract sub-datasets for more specific studies. This enables a fast 
and effective analysis, using only a fraction of the resources a full-set analysis would 
require. A scripting interface in the downstream analysis makes it possible to automate 
repetitive tasks and plug in new in-house implemented methods for data analysis and 
storage. Scripting is handled by a Jython interface (http://www.jython.org) which is an 
implementation of the popular python language in java, as well as providing scripting 
access to all java libraries (including standard libraries, downloaded libraries such as 
those for scientific and statistical computing and J-Express libraries). 
 
Many methods for data management and transformation exist J-Express. Some important 
tools are the annotation manager which can merge annotation information (such as 
database accession numbers and gene description), and the filtering tool for removing 
uninteresting genes based on properties like missing values and expression variation. 
 
Some external net-resources are also available in J-Express. One net-feature is the 
automatic download of Affymetrix CDF (Chip Definition File) files when only CEL-files 
are available. Other net resources include a server-side dataset repository for sharing 
datasets and automatic installation of software updates. 
 
The charts and graphical results produced by J-Express can be exported to many different 
image-formats. Importantly, J-Express can export vector graphics (in contrast to bitmap 
graphics) which greatly improves quality both on-screen and printed versions. 
 
The J-Express interface is generally easy to use and is designed in such a way that it 
should be easy to apply various methods to the data. The flexibility can however lead to 
unwanted processing. For instance, in the low level data preparation component, one can 
add filters and normalization methods (called processes) in a table. The process at the top 
of the table will be applied first and the bottom process will be applied last. If a 
normalization process is placed at the top and a filter process below, this will lead to a 
normalization based on unfiltered data (including control spots, empty spots, flagged 
43 
spots etc.) which is not necessarily a good way to perform normalization. By putting the 
filter process above the normalization process, the normalization is based only on good 










Figure 20:  The preprocessing framework in J-Express shown here with two pairs of 
process stacks and log-log plots (see Figure 7 for information about the log-log plots). 
The left windows show the preprocessing functionality with microarrays and a process 
stack. Each row in the stack is referred to as a process and can alter or display the data. 
When executed, the processes will be applied to the data from top to bottom if not 
disabled (by un-checking the USE box). The right charts show the plot process in the 
process stack after the blue processes above it have been applied to the data. The top 
process window and log-log plot shows a process with some filter steps first, then a 
global lowess normalization process. This leaves all filtered (red) spots in the right log-
log chart unchanged (and neglected by the normalization method). In the bottom process 
window and log-log plot the normalization process has been moved to the top of the 
stack, resulting in normalization before filtering. 
 
It is always possible to inspect the complete line of data-transformations and analysis 
steps performed in a J-Express analysis. This is handled in the J-Express project tree 
where each data-transformation or analysis step is added as a new dataset and linked to 
the source (as a child node in a graph). Each new dataset also contains a list of all 
methods (and method parameters) performed from the root dataset to the leaf. This makes 
it possible to recreate any analysis, and to go back and redo steps with different 
parameters when desirable. 
 






























Many ways of controlling the data and analysis quality are also integrated in J-Express. 
This is necessary because an analysis method performing well on one dataset does not 
necessarily give good results on any dataset. For instance, when normalizing data it can 
be of great value to see how the normalized data is distributed so that the parameters can 
be changed if the results are bad (see Figure 20). 
 
J-Express version 2.7 contains a codebase with over 220.000 lines of java code. 
Disregarding a few percent programmed by collaborators and some open source 
elements, most has been programmed during the master and Ph.D projects of the thesis 
author. Besides this codebase, J-Express also uses many precompiled public libraries 
such as JFreeChart for some of the graphics, JSCI (http://jsci.sourceforge.net) for math 
and statistics and JAMA (http://math.nist.gov/javanumerics/jama) for matrix calculations.
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6 Summary of papers 
 
Manuscript 1: 
Trond Hellem Bø, Bjarte Dysvik and Inge Jonassen: LSimpute: Accurate estimation of 
missing values in microarray data with least squares methods. Nucleic Acids 
Research, 2004, Vol. 32, No. 3 e34 
 
Missing elements in gene expression data is a frequently occurring problem. As the 
microarrays that constitute the expression matrix are processed to ensure data quality, a 
varying number of spots are usually considered less trustworthy because of artifacts such 
as weak foreground signals (close to-, or mixed with background), dust, scratches and 
saturation. Some analysis methods can disregard these spots and some methods even 
make use of confidence levels in calculation, but in many cases a complete matrix is 
required. 
 
We have proposed a method for imputing missing data in a gene expression matrix based 
on least squares regression. The success rate for this method is compared to one of the 
mostly applied missing value imputation methods, KNN impute and found superior for 
three public datasets. 
 
LSimpute estimates missing values in the dataset by using existing information from the 
most correlated genes and samples. LSimpute_gene is a sub-method that calculates a 
result based on regression from the 10 most correlated genes. Similarly, LSimpute_array 
calculates a result based on regression from the most correlated arrays. We found that 
these two methods complement each other and often yield a better estimate when 
combined than individually.  
 
We also implemented two methods for imputation based on expectation maximization; 
EMimpute_gene and EMimpute_array. These two are similar to the regression based 
estimation methods LSimpute_gene and LSimpute_array, but use a maximum likelihood 
estimate of the covariance matrix instead of the empirical covariance matrix. Both of 
these methods, EMimpute_array particularly, were able to compete with the least squares 




Bjarte Dysvik, Endre N. Vasstrand, Roger Løvlie, Osman A-Aziz Elgindi, Kenneth W. 
Kross, Hans J. Aarstad, Anne Chr. Johannessen, Inge Jonassen, and Salah O. Ibrahim: 
Gene Expression Profile of Head and Neck Carcinomas Between Patients from 
Sudan and Norway Reveals Common Biology Regardless of Differences Related to 
Ethnicity and Life Style. Clinical Cancer Research. 2006;12:1109-20. 
 
The objective for this work was to look for gene expression differences between disease 
tissue and normal tissue in head and neck samples and to see if there were any consistent 
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differences between patients from Sudan and patients from Norway. Because samples 
were gathered in different environments and from different locations in head and neck, 
the experimental design was one of the most challenging parts of this study. We chose to 
use several independent experimental designs and perform a meta analysis on the results.  
 
A total of 8 separate gene expression studies from 72 Norwegian and 45 Sudanese 
samples were performed using 7 pairwise disease vs. normal designs and 1 disease and 
normal vs. a common reference design. The individual analysis of the 8 groups revealed 8 
lists of interesting genes with lengths ranging from 35 to 578 candidate genes. We then 
searched for genes overrepresented between these lists by counting in how many lists 
each gene was found. The scores were compared to a similar study with 100 random 
generated lists of the same lengths as the candidate lists. This revealed a statistical 
significance of the top scoring genes. These genes were then subjected to further studies 
such as search for overrepresentation in metabolic pathways and gene ontology groups.  
 
The results were also compared to genes found differentially expressed in 9 other similar 
studies as well as the HNCGAP (Head and Neck Cancer Genome Anatomy Project) 
database. Some patterns were found and suggest that habits such as snuff use which are 




Bjarte Dysvik, Trond Hellem Bø and Inge Jonassen: Mixture models applied to 
microarray gene expression data 
 
Feature selection and class prediction are frequent tasks in microarray data analysis. 
Feature selection is the process of selecting a subset of genes possessing a predictive 
property. This subset can then be used by a classifier method to “learn” a class dividing 
pattern which can be used to predict class membership of new unstudied samples. Many 
feature selection methods exists such as t-tests, SAM, and 1-way ANOVA, and many 
classifier methods exist, such as Linear Discriminant analysis (LDA) and Support Vector 
Machines (SVM).  
 
In this project, we propose a new method for feature selection and classification based on 
mixture models. The mixture models are composed of nj normal distributions for each 
group, where nj is the number of measurements for group j. The motivation for this 
approach is the assumption of a not necessarily normal distribution of sample 
measurements and with that a better result with more flexible models. The flexibility is 
provided by the mixture model which (by modifying the standard deviation for the 
underlying normal distributions) can vary from strongly overfitted (low model standard 
deviations) to a normal density distribution. We suggest that somewhere in between these 
two values is a shape flexible enough to adapt to more than one single distribution while 
rigid enough to avoid overfitting. 
 
We used two ways of estimating the success rate of the method (leave one out cross 
validation and leave one third out cross validation) and compared the results from 6 
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5 The J-Express software 
J-Express is a software tool for analysis, organization and visualization of microarray 
data. Since its beginning in 1998, the software has evolved from being a simple collection 
of a few popular methods for expression analysis to a relatively advanced framework for 
low-level data preparation, expression analysis and data storage. As one of the first 
software providers we have integrated MAGE support both for data import and export. 
The MAGE export includes information about algorithm parameters and software 
settings. This information is automatically logged as data analysis proceeds, normally 
from normalization and filtering of single arrays to advanced analysis methods and often 
finally to the discovery of one or more gene-lists with interesting genes and their 
expression values. We have been working directly on the MAGE software toolkits to 
enable effective transportation and storage of microarray analysis results, which normally 
consists of large amounts of data, while still retain the information necessary to reproduce 
the results. One of the implemented solutions was to store only the data going into the 
first step of analysis and the data coming out of the last step (see Figure 19). In addition, 
we stored a description of the software package used, including a description, parameters 
and version number of all methods used in the analysis. This should be everything needed 
to recreate the results based on the same input. In addition, it reduced the size of the data 
package dramatically by leaving out intermediate results.  
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publicly available datasets. The results from all test datasets were promising and show 
that this method can compete and event outperform many of the most popular methods 




Inge Jonassen and Bjarte Dysvik: Current Protocols in Bioinformatics. John Wiley & 
Sons, Inc. Chapter 7 Analyzing Expression Patterns, Unit 7.3 Analysis of Gene-
Expression Data Using J-Express. 
 
This chapter in the collection of protocols in bioinformatics describes a stream-lined 
execution of certain expression analysis tasks using the J-Express software tool. Data 
analysis is generally organized into 3 different steps; importing image quanitation data, 
preprocessing array data and downstream analysis of a gene expression matrix (the first 
and second step can be bypassed by loading a tab-delimited pre-processed gene 
expression matrix). The first step involves using a framework for importing image 
quantitation data from different image analysis systems. The second step describes a 
preparation pipeline for generating a gene expression matrix from many image 
quantitation files. This includes filtering, normalization, data transformation and all 
processing needed on each array to enhance data quality and make data from each array 
comparable to data from other arrays. The third step involves analysis of a gene 
expression matrix. Many methods for expression matrix analysis are presented in the 
protocol, including profile searching, clustering and projection. A synthetic sample 
dataset is used to show differences between some of the implemented methods in a 
comprehensible way.  
 
Important concepts in this description of the J-Express software are those of a dataset and 
meta data. Each collection of data in the form of an expression matrix and annotation (on 
genes and samples) is stored in an object referred to as a dataset. Also included in this 
dataset is group information about genes and samples and a list containing meta data. 
Whenever a subset of genes or samples is extracted from the dataset or the data is altered 
in any way, a new dataset object is created and added as a child node. The child node 
meta list is then supplied with a new method description with detailed information about 
the process leading from the original dataset to the child dataset. Thus, a data analysis 
project using J-Express can be organized in the form of a tree with the original gene 
expression matrix at the root and branches with transformed and extracted data in 
branches and leaves. From any dataset node, one can view the meta list and re-create the 





Mai Lill Suhr, Bjarte Dysvik, Ove Bruland, Saman Warnakulasauriya, Asoka N. 
Amaratunga, Inge Jonassen, Endre N. Vasstrand and Salah O. Ibrahim: Gene 
Expression Profile of Oral Squamous Cell Carcinomas from Sri Lankan Betel Quid 
Users 
 
Oral squamous cell carcinoma (OSCC) is a major health problem in Southeast Asia. It is 
believed that the widespread use of betel quid (a chewed mixture of areca nut, lime and 
catchu wrapped in a betel leaf, often with tobacco added) in this area is in some way 
related to the high occurrence of this disease. In this project, we collected tumor and 
corresponding normal tissue from 15 patients from Sri Lanka with OSCC diagnosis. RNA 
from each of these was extracted, labeled and hybridized to microarrays created by the 
Norwegian microarray consortium. After scanning and image analysis, data processing 
and analysis revealed 263 candidate genes found differentially expressed between normal 
and tumor samples. Further investigation of these genes using Gene Ontology groups and 
KEGG pathway information revealed significant overlap between the candidate genes 
and ontology terms and KEGG pathways. When searching for previously reported genes 
in relation to head and neck cancer, we found 66 of the 263 genes previously reported. 
Hierarchical clustering of the tissues using the 263 differentially expressed genes also 
revealed correlation between samples and factors such as tumor grade and size. 
 
From an informatics and statistical point of view this project presented us with some 
serious challenges, much because the experimental design and hybridizations were 
conducted prior to the involvement of our department. The biologists chose a pairwise 
tumor vs. normal hybridization design with dye completely confounding with tumor state 
and without including dye-swap hybridizations. This generally made deciding a gene to 
be differentially expressed due to tumor progression impossible, without estimating the 
dye-gene specific effects. These effects were approximated in two ways. First, we 
excluded all genes reported to have dye effects by the microarray manufacturer. Second, 
an experiment using different tumor and normal samples, but the same microarrays and 
protocols were prepared. This experiment included dye-swaps for all sample pairs. When 
a gene was found significantly differentially expressed in our dataset (using a regularized 
t-score), the same gene was controlled for dye-specific effect in the dye-swap dataset. 
Although this procedure did not give us a 100% reliable dataset, any dye-effect still 
present should not contribute to analyses such as those including Gene Ontology or 
KEGG pathway information (under the assumption that dye effects should not be 
dependent on biological functions). 
 
By further manual analysis of the 263 candidate genes, we found many genes of special 
interest for further studies. These includes genes previously reported as being correlated 
with tumor progression and some unreported genes involved in relevant biological 




Christiane Moros, Petter Frost, Bjarte Dysvik, Bjørn Kristiansen, Inge Jonassen and 
Frank Nilsen: Identification of transcripts regulated during sexual maturation and 
egg production in adult female salmon lice Lepeophtheirus salmonis (Crustacea, 
Copopoda), using EST-sequencing and microarray analysis 
 
In this project, the goal was to study the maturation of the female salmon louse. Salmon 
louse (Lepeophtheirus salmonis) is a severe problem for the Norwegian aquaculture 
industry. We created a cDNA microarray by printing clones from a salmon louse EST 
library onto a microarray with assistance from the Norwegian Microarray Consortium. 
These microarrays were used to measure the relative expression of mRNA from 35 
salmon lice divided into 7 development stages (a pre adult stage and stages T1 – T6 by 
visual inspection). We used reference hybridization design with a common reference 
created from a mixture of pooled mRNAs from different developmental stages and sexes. 
After data preparation and quality control, we compiled a gene expression matrix and 
grouped together lice from the same development stage. Gene targets in our downstream 
analysis were genes expressed differentially between the development stages. We created 
a group-wise expression matrix by combining expression values for all samples in the 
same developmental group using a trimmed mean. Prior to creating this matrix, we 
verified a high expression similarity among lice in the same group by methods such as 
principal component analysis and Self-Organizing Maps (SOMs).  
 
Simple cluster analysis (SOM) revealed two expression patterns differing from the global 
none-changed pattern. One of the patterns were high expressed in the early stages of 
development but decreased in the late stages. The other pattern showed a low expression 
in the early stages and up-regulation during maturation. Further analysis involving both 
ESTs and samples in a bi-plot (correspondence analysis) also revealed a third pattern, 
similar to the first pattern, but with a high expression in the pre adult stage and very low 
expression in the latter stages. Genes with known function in the two first groups showed 
as expected growth related genes in the first pattern (being down-regulated) and 
reproduction genes in the second pattern (being up-regulated). Within these groups were 





Bjarte Dysvik and Inge Jonassen . J-Express: exploring gene expression data using 
Java. Bioinformatics, 17, 369-370 (2001) 
 
Ayodele A. Alaiya, Bo Franzén, Anders Hagman, Bjarte Dysvik, Uwe J. Roblick, 
Susanne Becker, Birgitta Moberger, Gert Auer, Stig Linder. Molecular classification of 
borderline ovarian tumors using hierarchical cluster analysis of protein expression 
profiles. International Journal of Cancer, Volume 98, Issue 6, 2002, 895 - 899 
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7 Further work  
The field of microarray data analysis is beginning to “grow up”, at least compared to 
some of the methods used in the first publications. In addition, the underlying microarray 
technology, including labeling technology, hybridization techniques, microarray 
production, storage and scanners have improved dramatically the last couple of years. 
Prices have been reduced, enabling researchers to use microarrays more frequently, and 
in greater number. In addition, microarrays are now packed with more and smaller spots, 
producing considerable more data than before. More knowledge about genes and 
genomes are stored in public databases, and the number of sequenced organisms continue 
to grow. All these things are constantly affecting how microarray data analysis is 
performed. 
 
The size of a microarray experiment is now often hundreds of samples with as much as 
40.000 measurements. Compared to some of the first datasets, such as those containing 
abundance of 6124 yeast genes in 15-20 time points (e.g. Spellmans based cell cycle 
experiment using elutriation [79]) these datasets are often too large for efficient analysis 
using the same conventional algorithms. Although both computer power and physical 
memory size has increased together with the data size, some methods are still increasing 
exponentially in efficiency and time usage. An example is the frequently used 
hierarchical clustering method which takes at least a factor O(n2) time, and some 
implementations still takes O(n3) time and O(n2) space. Using an O(n3) algorithm means 
that doubling the sample size increases time usage by an eightfold, in a best case 
scenario. For such algorithms, we often need to reduce the data size by filtering 
uninteresting data (again, halving the data size will reduce time usage by an eightfold), or 
we must develop and implement more efficient algorithms. This is often done by using 
heuristics which reduces time and space complexity by only promising an approximation 
of the correct answer. 
 
Developing software for microarray analysis has proven to be a challenge much because 
of the many different microarray vendors and their constant modifications and 
development of new standards. We have overcome some problems by keeping our 
software up to date through an automatic software update system. This automatically 
adds new functionality and software patches for users connected to the internet. The 
users’ choice of technology and methods are often changing, meaning that a software 
package will soon be outdated if not flexible enough to adapt the new microarray 
“fashions” quickly. 
 
Developing novel methods for microarray data analysis is still an important task in 
bioinformatics. The reason why this field has not yet converged with accepted standard 
methods is the constant improvement of technology and addition of new knowledge 
about genes and genomes. For instance, new unsupervised clustering methods have been 
frequently proposed in various microarray and bioinformatics journals for many years. 
With the large amount of metabolic pathway and gene ontology information available in 
various databases, clustering methods are now used together with this information to 
perform a so-called semi-supervised clustering. This seems to be a trend in new 
51 
algorithms and a challenge for developers. Collecting information from various databases 
around the world and keeping it updated and formatted before supplying it to analysis 
methods is difficult but essential. Future work in algorithm development for microarray 
analysis and decision making (e.g. deciding genes relevant to phenotypic changes) should 
include as much relevant information as possible. 
 
Analysis methods where data from multiple experiments is analyzed together to reveal 
cross-experimental relations and global patterns between genes and samples is left for 
future work. Publications where this has been done do exist (e.g. Rhodes et. al. 2004 
[80]), but there is still a need for this information to be efficiently used in the data 
analysis software.  
 
The J-Express software has much room for improvement. More downstream data analysis 
methods such as Support Vector Machines (SVM), and Partial Least Squares (PLS) 
should be added and new options for data transformation (variance stabilization) and 





Microarray technology has come a long way since we started working on analysis 
methods in 1998. Reproducibility has increased, collaborators have moved between 
microarray vendors several times and heaps of analysis methods have been proposed. 
When looking back, we find applied methods in our projects that can be replaced by 
better ones in almost every phase of the analysis, even for projects only a couple of years 
old. For instance, in the Sudan-Norway carcinoma analysis [81] we were uncertain about 
how to handle the large variation between samples when looking for genes differentially 
expressed between tumor and normal tissue. In the beginning, we included a negative 
variance factor in the equation, but we soon found that this variation was really not 
important as long as the expression values were significantly over- or under expressed 
between tumor and normal samples. Today, we find many methods for microarray data 
analysis perhaps better suited for this analysis, such as regularized t-scores and SAM. 
 
In the papers included in this thesis, we present novel methods for preparing and 
analyzing microarray gene expression data. In addition, we present projects where 
analysis methods have been applied to new datasets provided by collaborators. We have 
shown that even though the underlying data is noisy, there are still ways to bring out 
genes and show that they have a statistical significance. When the underlying data is of 
high quality, the analysis methods are simpler and easier to validate. It is tempting to 
suggest that whenever the data is of high quality, fewer samples are needed to discover 
significant biological meaning. This does however not mean that as long as there are 
enough data of low quality, we can always bring out the “gold” from the dross.  
 
A recurring issue when dealing with microarray data is how to prepare the data for 
downstream expression analysis. The importance of preprocessing are tightly linked to 
the accuracy of the microarray technology. As long as the measurements are less than 
perfect, preprocessing will be a crucial step in the analysis. Another important factor in 
the preparation phase is how to get the most out of the image analysis. Most computer 
software packages for image processing and analysis provide a wide collection of 
statistics. This information should be carefully processed to optimize result quality. 
Studies show that different habits in filtering, imputation and normalization can give 
fundamentally different results.  
 
Filtering in the data preparation step usually includes removing bad spots. The definition 
of a bad spot is however not always agreed upon. We have shown that patterns in the 
dataset can be used to impute filtered spots and further work in this field should explore 
what kind of filtering is best suited for imputation. For instance, spots damaged by dust 
and scratches and thereby filtered and imputed may result in better results than spots 
filtered due to weak signals (low expression).  
 
When calculating a success rate for the various imputation methods, we hid values for 
imputation arbitrarily in the expression matrix and compared an imputed value to the 
hidden value. The rate of missing values is however not necessarily randomly distributed 
53 
across genes. A better comparison could be to test the success rate only for genes that are 
more likely to contain missing values, such as genes with low intensities across samples. 
In addition, using external information such as functional groups could further increase 
similarity confidence when calculating correlation between genes to use in correlation 
based imputation. 
 
The vast amount of methods available for expression analysis illustrates the microarray 
range of applications and complexity. It also seems that the imperfect nature of a 
microarray experiment appeal to a variety of academic fields, including statisticians, 
mathematicians and computer scientists. We have implemented many methods for 
microarray data analysis and found strengths and weaknesses in many of them. 
Generally, it seems that most methods produce good results when applied to high quality 
data. In addition, strong signals such as a high average, low within group variance fold 
change between two groups are always picked up in a discriminant study, while other 
signals such as a similar fold change but high within group variance need special 
treatments (for instance regularized t-score vs. traditional t-score).  
 
For any discriminant study, a permutation test should be applied to establish a 
background score. Again, the inaccurate nature of the expression matrix demands results 
to be verified statistically. 
 
Another recurring issue in microarray experiments is the biologist’s failure to bring in the 
statistical and bioinformatics expertise at an early enough stage. An example is the 
Sudan-Norway carcinoma analysis [81] where the experimental design and most of the 
hybridizations were already done at the time our group was involved. In addition, 
samples were harvested after the initial hybridizations were processed and microarrays 
had to be bought from different batches as the experiment grew in size. Different parts of 
the experiment were hybridized using different designs (common reference and direct 
hybridizations) which made direct comparison between all samples impossible. Getting 
results from this dataset proved to be a tremendous challenge, but the applied analysis did 
result in some significant genes and biological processes. For optimal results, statisticians 
should be included as early as possible in the idea and planning phase of a microarray 
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